US Stock MarketDetailed Quotes

ZURA Zura Bio

Watchlist
  • 5.490
  • -0.150-2.66%
Close May 24 16:00 ET
  • 5.630
  • +0.140+2.55%
Post 19:53 ET
349.62MMarket Cap-3978P/E (TTM)

Zura Bio Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-52.96%-4.98M
-1,152.41%-15.05M
-4.05M
-2.57M
-5.17M
-3.26M
-9.46%-1.2M
-1.1M
Net income from continuing operations
20.91%-7.75M
-121.57%-60.56M
---8.47M
---8.27M
---34.03M
---9.8M
-499.10%-27.33M
--6.85M
Operating gains losses
447.02%583K
-3,321.74%-741K
---983K
--288K
--122K
---168K
100.27%23K
---8.48M
Other non cash items
----
41.59%31.48M
--0
--0
--27.38M
--4.1M
2,776.33%22.23M
--772.97K
Change In working capital
-193.80%-227K
44.48%5.12M
--3.01M
--2.83M
---969K
--242K
1,602.96%3.54M
---235.6K
-Change in receivables
----
----
----
----
----
----
----
--2.87K
-Change in prepaid assets
278.40%380K
-296.17%-828K
---304K
---203K
---108K
---213K
50.58%-209K
---422.89K
-Change in payables and accrued expense
-233.41%-607K
58.51%5.94M
--3.31M
--3.04M
---861K
--455K
1,933.40%3.75M
--184.42K
Cash from discontinued investing activities
Operating cash flow
-52.96%-4.98M
-1,152.41%-15.05M
---4.05M
---2.57M
---5.17M
---3.26M
-9.46%-1.2M
---1.1M
Investing cash flow
Cash flow from continuing investing activities
-5.01M
33.33%-8M
0
-2.25M
-5.75M
0
91.39%-12M
-139.38M
Net PPE purchase and sale
---7K
----
----
----
----
--0
----
----
Net intangibles purchase and sale
---5M
33.33%-8M
--0
---2.25M
---5.75M
--0
---12M
----
Net other investing changes
----
----
----
----
----
----
----
---139.38M
Cash from discontinued investing activities
Investing cash flow
---5.01M
33.33%-8M
--0
---2.25M
---5.75M
--0
91.39%-12M
---139.38M
Financing cash flow
Cash flow from continuing financing activities
0
721.27%121.29M
0
-4.12M
79.76M
45.65M
-89.54%14.77M
141.21M
Net issuance payments of debt
--0
-231.58%-10M
--0
--0
--0
---10M
6,574.64%7.6M
---117.38K
Net common stock issuance
--0
--116.41M
--0
---4.12M
--63.85M
--56.68M
--0
--138M
Net preferred stock issuance
----
--0
--0
--0
----
----
--10M
----
Proceeds from stock option exercised by employees
----
--16.07M
--0
--0
----
----
--0
----
Net other financing activities
----
58.18%-1.18M
--0
--0
---154K
---1.03M
-185.15%-2.83M
--3.32M
Cash from discontinued financing activities
Financing cash flow
--0
721.27%121.29M
--0
---4.12M
--79.76M
--45.65M
-89.54%14.77M
--141.21M
Net cash flow
Beginning cash position
6,269.24%99.81M
--1.57M
--103.86M
--112.8M
--43.96M
--1.57M
--0
--0
Current changes in cash
-123.56%-9.99M
6,169.24%98.24M
---4.05M
---8.94M
--68.84M
--42.4M
114.89%1.57M
--729.22K
End cash Position
104.30%89.82M
6,269.24%99.81M
--99.81M
--103.86M
--112.8M
--43.96M
114.89%1.57M
--729.22K
Free cash flow
-206.69%-9.99M
-74.63%-23.05M
---4.05M
---4.82M
---10.92M
---3.26M
-1,102.21%-13.2M
---1.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -52.96%-4.98M-1,152.41%-15.05M-4.05M-2.57M-5.17M-3.26M-9.46%-1.2M-1.1M
Net income from continuing operations 20.91%-7.75M-121.57%-60.56M---8.47M---8.27M---34.03M---9.8M-499.10%-27.33M--6.85M
Operating gains losses 447.02%583K-3,321.74%-741K---983K--288K--122K---168K100.27%23K---8.48M
Other non cash items ----41.59%31.48M--0--0--27.38M--4.1M2,776.33%22.23M--772.97K
Change In working capital -193.80%-227K44.48%5.12M--3.01M--2.83M---969K--242K1,602.96%3.54M---235.6K
-Change in receivables ------------------------------2.87K
-Change in prepaid assets 278.40%380K-296.17%-828K---304K---203K---108K---213K50.58%-209K---422.89K
-Change in payables and accrued expense -233.41%-607K58.51%5.94M--3.31M--3.04M---861K--455K1,933.40%3.75M--184.42K
Cash from discontinued investing activities
Operating cash flow -52.96%-4.98M-1,152.41%-15.05M---4.05M---2.57M---5.17M---3.26M-9.46%-1.2M---1.1M
Investing cash flow
Cash flow from continuing investing activities -5.01M33.33%-8M0-2.25M-5.75M091.39%-12M-139.38M
Net PPE purchase and sale ---7K------------------0--------
Net intangibles purchase and sale ---5M33.33%-8M--0---2.25M---5.75M--0---12M----
Net other investing changes -------------------------------139.38M
Cash from discontinued investing activities
Investing cash flow ---5.01M33.33%-8M--0---2.25M---5.75M--091.39%-12M---139.38M
Financing cash flow
Cash flow from continuing financing activities 0721.27%121.29M0-4.12M79.76M45.65M-89.54%14.77M141.21M
Net issuance payments of debt --0-231.58%-10M--0--0--0---10M6,574.64%7.6M---117.38K
Net common stock issuance --0--116.41M--0---4.12M--63.85M--56.68M--0--138M
Net preferred stock issuance ------0--0--0----------10M----
Proceeds from stock option exercised by employees ------16.07M--0--0----------0----
Net other financing activities ----58.18%-1.18M--0--0---154K---1.03M-185.15%-2.83M--3.32M
Cash from discontinued financing activities
Financing cash flow --0721.27%121.29M--0---4.12M--79.76M--45.65M-89.54%14.77M--141.21M
Net cash flow
Beginning cash position 6,269.24%99.81M--1.57M--103.86M--112.8M--43.96M--1.57M--0--0
Current changes in cash -123.56%-9.99M6,169.24%98.24M---4.05M---8.94M--68.84M--42.4M114.89%1.57M--729.22K
End cash Position 104.30%89.82M6,269.24%99.81M--99.81M--103.86M--112.8M--43.96M114.89%1.57M--729.22K
Free cash flow -206.69%-9.99M-74.63%-23.05M---4.05M---4.82M---10.92M---3.26M-1,102.21%-13.2M---1.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg